Status:
COMPLETED
Hematological Manifestations in Systemic Lupus Erythematosus Patients
Lead Sponsor:
Patan Academy of Health Sciences
Conditions:
Systemic Lupus Erythematosus (SLE)
Eligibility:
All Genders
Brief Summary
The goal of this observational study is to evaluate hematological abnormalities among patients with systemic lupus erythematosus (SLE) admitted to a tertiary care center in Nepal. The main question it...
Eligibility Criteria
Inclusion
- All the patient diagnosed with systemic lupus erythematosus based on 2019 European League of Associations for Rheumatology and American College of Rheumatology (2019 EULAR/ACR) criteria.
Exclusion
- Underlying hematological diseases or conditions: Patients who had hematological disease (e.g. hemophilia, leukemia, lymphoma) or conditions that could independently affect hematological parameters.
- Incomplete records
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT06936007
Start Date
November 1 2024
End Date
December 30 2024
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Patan Hospital
Lalitpur, Bagmati Province, Nepal, 44700